Is An Accelerated Approval Likely For Cassava Sciences?
Cassava Sciences has a promising Alzheimer’s Drug candidate. See why I believe SAVA’s Simufilam drug is a likely candidate…
Cassava Sciences has a promising Alzheimer’s Drug candidate. See why I believe SAVA’s Simufilam drug is a likely candidate…
The transition to a low carbon economy is well underway, but significant action is still required to meet aggressive…
Black Friday is your chance to grab a bargain on the best laptops around. Here are the deals we’ve…
Electromedical Technologies, Inc. (OTCQB: EMED) (the “Company”), a pioneer in the development and production of bioelectronic…
This post contains a video, which you can also view here. To support more videos like this, head to…
BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) — Block & Leviton is investigating Standard Lithium Ltd. (NYSE: SLI) for potential…
Alibaba’s September 2021 quarter misses on multiple fronts, with growth outlook lowered. Check out why I am downgrading my…
New to the market via SPAC deal, Matterport needs to prove itself as a public company. Here’s why there’s…
These three Canadian pot companies sport key features that should allow them to reward patient shareholders.